LACOSAMIDE for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 842 adverse event reports in the FDA FAERS database where LACOSAMIDE was used for Off label use.
Most Reported Side Effects for LACOSAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Seizure | 4,585 | 21.6% | 197 | 1,763 |
| Drug ineffective | 2,945 | 13.9% | 237 | 1,102 |
| Off label use | 2,811 | 13.3% | 296 | 1,037 |
| Dizziness | 974 | 4.6% | 10 | 257 |
| Overdose | 971 | 4.6% | 72 | 376 |
| Generalised tonic-clonic seizure | 918 | 4.3% | 29 | 314 |
| Epilepsy | 902 | 4.3% | 52 | 306 |
| Status epilepticus | 874 | 4.1% | 129 | 491 |
| Fall | 780 | 3.7% | 42 | 418 |
| Somnolence | 768 | 3.6% | 27 | 273 |
| Multiple-drug resistance | 739 | 3.5% | 83 | 155 |
| Fatigue | 698 | 3.3% | 16 | 206 |
| Death | 679 | 3.2% | 679 | 78 |
| Maternal exposure during pregnancy | 627 | 3.0% | 18 | 74 |
| Headache | 561 | 2.6% | 6 | 166 |
Other Indications for LACOSAMIDE
Epilepsy (5,941)
Seizure (5,700)
Product used for unknown indication (4,678)
Partial seizures (1,479)
Status epilepticus (1,445)
Generalised tonic-clonic seizure (495)
Focal dyscognitive seizures (259)
Partial seizures with secondary generalisation (172)
Temporal lobe epilepsy (142)
New onset refractory status epilepticus (110)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)